A Comprehensive Analysis of Pyroptosis-Related lncRNAs Signature Associated With Prognosis and Tumor Immune Microenvironment of Pancreatic Adenocarcinoma

被引:11
|
作者
Zhao, Kai [1 ]
Li, Xiangyu [1 ]
Shi, Yuanxin [1 ]
Lu, Yun [1 ]
Qiu, Peng [1 ]
Deng, Zhengdong [1 ]
Yao, Wei [2 ]
Wang, Jianming [1 ,3 ]
机构
[1] Huazhong Univ Sci & Technol, Affiliated Tongji Hosp, Tongji Med Coll, Dept Biliary & Pancreat Surg,Canc Res Ctr, Wuhan, Peoples R China
[2] Huazhong Univ Sci & Technol, Affiliated Tongji Hosp, Tongji Med Coll, Dept Oncol, Wuhan, Peoples R China
[3] Wuhan Univ Sci & Technol, Affiliated Tianyou Hosp, Wuhan, Peoples R China
基金
中国国家自然科学基金;
关键词
pancreatic adenocarcinoma; pyroptosis; lncRNAs; prognosis; tumor immune microenvironment; immunotherapy; CELL-DEATH; CANCER STATISTICS; PROMOTES; PATHWAY;
D O I
10.3389/fgene.2022.899496
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Globally, pancreatic adenocarcinoma (PAAD) is a common and highly devastating gastrointestinal malignancy that seriously threatens human health. Pyroptosis refers to an emerging form of programmed cell death that has been discovered in recent years, and studies have demonstrated that long non-coding RNA (lncRNA) may act as a moderator in the pyroptosis process of cancer cells. However, relevant explorations about lncRNAs and pyroptosis are still insufficient in PAAD. Therefore, our research is designed to make a comprehensive analysis of the potential values of pyroptosis-related lncRNAs in PAAD.Methods: By integrating the RNA-sequencing, somatic mutation, and copy number variation (CNV) datasets, as well as the clinicopathological features, we established and validated a risk signature based on pyroptosis-related lncRNAs, and comprehensively analyzed its clinical significance and the potential connection with the tumor immune microenvironment (TIME).Consequences: The genetic variation landscape displayed that the somatic mutations were rare while CNV changes were general and mainly concentrated on copy number amplification of these 52 pyroptosis-related genes. Subsequently, a risk signature consisting of 10 lncRNAs (TRAF3IP2-AS1, LINC00519, LINC01133, LINC02251, AC005332.6, AL590787.1, AC090114.2, TRPC7-AS1, MIR223HG, and MIR3142HG) was constructed and patients were divided into different subgroups according to the median risk score; patients with high-risk scores presented worse outcomes compared to those with low-risk scores in the training, testing, and entire cohorts. Furthermore, patients at low-risk scores possessed a higher infiltration abundance of immune cells compared with high-risk patients, which was consistent with the expression levels of lncRNAs between the high/low-risk groups. Drug sensitivity analysis showed that low-risk scores were related to anti-cancer agents like AICAR and Axitinib, whereas high-risk scores were connected with certain drugs such as AUY922. These results demonstrated that our risk signature could be used for prognosis prediction; additionally, it was also related to the TIME that might act as a potential indicator to instruct immunotherapeutic strategies.Conclusion: This work explored the significance of the risk model constructed by pyroptosis-related lncRNAs in prognosis prediction and its internal link with the immune microenvironment of PAAD. The results are expected to assist in the diagnosis, prognostic assessment, and management of patients with PAAD.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] A pyroptosis-related gene signature predicting survival and tumor immune microenvironment in breast cancer and validation
    Gong, Mingkai
    Liu, Xiangping
    Zhao, Xian
    Wang, Haibo
    BMC CANCER, 2022, 22 (01)
  • [42] Comprehensive exploration of immune checkpoint-related genes in the prognosis and tumor immune microenvironment of pancreatic adenocarcinoma
    Chen, Xiao
    Zhang, Herui
    CLINICS, 2024, 79
  • [43] The signature of pyroptosis-related gene prognostic and immune microenvironment in adrenocortical carcinoma
    Gao, Jun
    Wang, Dai
    Yang, Qingping
    Tang, Mengjie
    Du, Jiayi
    He, Leye
    Liu, Wei
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
  • [44] Pyroptosis-Related LncRNA Signature Predicts Prognosis and Is Associated With Immune Infiltration in Hepatocellular Carcinoma
    Liu, Ze-Kun
    Wu, Ke-Fei
    Zhang, Ren-Yu
    Kong, Ling-Min
    Shang, Run-Ze
    Lv, Jian-Jun
    Li, Can
    Lu, Meng
    Yong, Yu-Le
    Zhang, Cong
    Zheng, Nai-Shan
    Li, Yan-Hong
    Chen, Zhi-Nan
    Bian, Huijie
    Wei, Ding
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [45] A pyroptosis-related gene signature predicting survival and tumor immune microenvironment in breast cancer and validation
    Mingkai Gong
    Xiangping Liu
    Xian Zhao
    Haibo Wang
    BMC Cancer, 22
  • [46] The pyroptosis-related gene signature predicts prognosis and indicates the immune microenvironment status of chronic lymphocytic leukemia
    Sha, Yeqin
    Jiang, Rui
    Miao, Yi
    Qin, Shuchao
    Wu, Wei
    Xia, Yi
    Wang, Li
    Fan, Lei
    Jin, Hui
    Xu, Wei
    Li, Jianyong
    Zhu, Huayuan
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [47] Prediction of immunotherapy response of bladder cancer with a pyroptosis-related signature indicating tumor immune microenvironment
    Xu, Zihan
    Zhao, Yujie
    Zhang, Yong
    Liu, Xiaowei
    Song, Linlin
    Chen, Meixu
    Xiao, Guixiu
    Ma, Xuelei
    Shi, Hubing
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [48] Pyroptosis-Related lncRNAs Predict the Prognosis and Immune Response in Patients With Breast Cancer
    Yang, Xia
    Weng, Xin
    Yang, Yajie
    Jiang, ZhiNong
    FRONTIERS IN GENETICS, 2022, 12
  • [49] A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma
    Zhu, Wenying
    Ye, Zhipeng
    Chen, Ling
    Liang, Haifeng
    Cai, Qian
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 101
  • [50] Prognosis and Characterization of Immune Microenvironment in Head and Neck Squamous Cell Carcinoma through a Pyroptosis-Related Signature
    Lu, Lin
    Zhang, Peiling
    Cao, Xiaofei
    Guan, Mingmei
    JOURNAL OF ONCOLOGY, 2022, 2022